SETD7 and diabetes mellitus: In contrast, very few molecules are being investigated for the treatment of CVD in DM, these encompass HDACi, for the treatment of diabetic cardiomyopathy (Garmpi et al. 2022), Set7 inhibitors, to rescue the vascular phenotype (Paneni et al. 2015a, b), and BET inhibitors.